- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/14
Total number of patents in this class: 1649
10-year publication summary
|
108
|
96
|
109
|
117
|
124
|
124
|
146
|
139
|
112
|
69
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1801 |
73 |
| Intra-Cellular Therapies, Inc. | 411 |
43 |
| Pharmacosmos A/S | 65 |
38 |
| Pharmacosmos Holding A/S | 197 |
38 |
| Merck Patent GmbH | 5823 |
35 |
| Novartis AG | 10850 |
29 |
| Agenebio, Inc. | 46 |
28 |
| Idemitsu Kosan Co., Ltd. | 4220 |
26 |
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Dana-Farber Cancer Institute, Inc. | 2564 |
21 |
| G1 Therapeutics, Inc. | 54 |
21 |
| Genentech, Inc. | 3980 |
20 |
| Bristol-myers Squibb Company | 4893 |
19 |
| Bayer Pharma AG | 1047 |
18 |
| Incyte Corporation | 1024 |
16 |
| Prelude Therapeutics, Incorporated | 130 |
16 |
| Samsung Display Co., Ltd. | 34798 |
15 |
| Duk San Neolux Co., Ltd. | 653 |
15 |
| Bayer AG | 3331 |
14 |
| The Board of Trustees of the Leland Stanford Junior University | 6416 |
14 |
| Other owners | 1127 |